Cargando…
High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer
AIM OF THE STUDY: The purpose of this study was to assess the concentration of urokinase-type plasminogen activator receptor (uPAR) in the serum of 103 women with breast cancer. Commonly recognized prognostic factors were taken into account, including age, histological grade of malignancy, stage of...
Autores principales: | Thielemann, Anna, Baszczuk, Aleksandra, Kopczyński, Przemysław, Kopczyński, Zygmunt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934023/ https://www.ncbi.nlm.nih.gov/pubmed/24596533 http://dx.doi.org/10.5114/wo.2013.38567 |
Ejemplares similares
-
The clinical usefulness of assessing the concentration of cell adhesion molecules sVCAM-1 and sICAM-1 in the serum of women with primary breast cancer
por: Thielemann, Anna, et al.
Publicado: (2014) -
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998) -
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987) -
Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
por: Ichihara, Noboru, et al.
Publicado: (2017) -
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)